Related Experiment Video
Updated: May 31, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Overexpression of SALL4 in lung cancer and its importance in cell proliferation
Daisuke Kobayashi1, Kageaki Kuribayashi, Maki Tanaka
1Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Abstract:
Few target molecules have been identified that enable the diagnosis of lung cancer with high sensitivity and specificity, especially in the early clinical stages. Herein, we present the first evidence for mRNA overexpression of SALL4, a transcription factor essential for embryonic development and the self-renewal of embryonic stem cells, in lung cancer. Analysis using cancerous and noncancerous tissues revealed that the sensitivity and specificity of SALL4 mRNA were 85.1 and 92.9%, respectively, estimated using the cutoff value obtained from analyzing the receiver operating characteristic curve. Furthermore, comparison of paired tissues from the same patient revealed elevated SALL4 mRNA levels that were greater than two-fold in 93% of the specimens. SALL4 mRNA was highly expressed even in the early clinical stages and there was no difference in the positivity rate between stage IA and other stages. An siRNA approach to determine the significance of SALL4 expression revealed catastrophic growth inhibition of SBC-1 lung cancer cells that was induced by cell cycle arrest at the G1/early S phase. Therefore, SALL4 mRNA may be a candidate for use as support in the diagnosis of lung cancer, and may also represent a therapeutic target.
Insights
SALL4 mRNA is overexpressed in lung cancer, showing high sensitivity and specificity for early diagnosis. Inhibiting SALL4 significantly halts lung cancer cell growth, suggesting its potential as a diagnostic marker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Limited availability of sensitive and specific biomarkers for early lung cancer diagnosis.
- SALL4, a transcription factor crucial for embryonic development and stem cell self-renewal, has not been previously investigated in lung cancer.
Purpose of the Study:
- To investigate SALL4 mRNA as a potential diagnostic biomarker for lung cancer.
- To explore the functional role of SALL4 in lung cancer cell proliferation.
Main Methods:
- Quantitative analysis of SALL4 mRNA expression in cancerous and noncancerous lung tissues.
- Receiver Operating Characteristic (ROC) curve analysis to determine diagnostic accuracy.
- Analysis of SALL4 mRNA levels in paired tumor and adjacent non-tumor tissues.
- Small interfering RNA (siRNA) mediated knockdown of SALL4 in lung cancer cells (SBC-1).
- Cell cycle analysis to assess the impact of SALL4 inhibition on cell proliferation.
Main Results:
- SALL4 mRNA was found to be overexpressed in lung cancer tissues.
- SALL4 mRNA demonstrated high diagnostic sensitivity (85.1%) and specificity (92.9%) for lung cancer.
- Elevated SALL4 mRNA levels (>2-fold) were observed in 93% of paired tumor samples.
- High SALL4 mRNA expression was consistent across early (Stage IA) and advanced lung cancer stages.
- siRNA-induced SALL4 knockdown resulted in significant growth inhibition of SBC-1 lung cancer cells.
- SALL4 inhibition led to cell cycle arrest at the G1/early S phase.
Conclusions:
- SALL4 mRNA overexpression is a significant finding in lung cancer, suggesting its potential as a novel diagnostic biomarker.
- SALL4 plays a critical role in lung cancer cell proliferation and survival.
- SALL4 represents a promising therapeutic target for lung cancer treatment.
Related Concept Videos
Abnormal Proliferation
Pleiotropy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming
